Skip to main content
CBIO filings

Corporate insider profile

Ryan Lynch Filing Activity

Latest reported as See Remarks of CRESCENT BIOPHARMA, INC. (CBIO).

Purchase filings
0
Reported companies
1
Net open-market value
-$8,365.35
Latest transaction
Jun 22, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 22, 2026CRESCENT BIOPHARMA, INC. (CBIO)See RemarksSale465$17.99$8,365